India-US trade talks are nearing the finish line. What’s at stake?

With India-US ministerial talks concluded in New Delhi on June 23–24, 2026, both sides are nearing the end of negotiations on a first-phase Bilateral Trade A...

What Happened

With India-US ministerial talks concluded in New Delhi on June 23–24, 2026, both sides are nearing the end of negotiations on a first-phase Bilateral Trade Agreement (BTA) — the first-ever structured preferential trade framework between the two nations.
The deal, if concluded, would reduce the US reciprocal tariff on Indian goods from the current 10% (above WTO MFN rates) to 18% on originating goods under the BTA, in exchange for Indian tariff concessions and market access commitments.
At stake is the competitiveness of India's top export sectors — textiles and apparel, pharmaceuticals, engineering goods, gems and jewellery — in the world's largest economy, which is simultaneously India's largest export destination.
The broader strategic prize is a rules-based trade architecture between the world's largest democracy and the world's largest economy — underpinning the US-India partnership across technology, defence, and supply chains.
Failure to conclude a deal before July 24, 2026 (expiry of the current 10% tariff regime) risks a return to higher tariff uncertainty, with India's goods facing potential escalation.

Static Topic Bridges

Sector-by-Sector Stakes in the India-US BTA

The BTA's impact varies sharply by sector. Some industries face structural transformation; others face only marginal shifts. Understanding the sector breakdown is essential for appreciating India's negotiating priorities.

Textiles and Apparel: India's second-largest goods export to the US (~USD 12–14 billion/year). These goods operate on thin margins; even a modest tariff reduction from 18% to lower rates would be transformative. The sector is the largest formal employer outside agriculture.
Pharmaceuticals: India is the world's largest supplier of generic drugs, supplying ~40% of US generic prescriptions by volume. A Section 232 investigation on pharma is ongoing in the US; the BTA would provide India negotiated outcomes on generics and active pharmaceutical ingredients (APIs) — shielding a USD ~8 billion export.
Gems and Jewellery: India's largest goods export category to the US (~USD 10–12 billion). Currently faces relatively lower MFN duties but is sensitive to tariff uncertainty.
Engineering Goods and Auto Parts: India has a preferential tariff rate quota commitment for automotive parts under the BTA framework; this sector benefits from supply chain integration with US assemblers.
Agricultural Imports from US: India has offered limited access for DDGs, red sorghum, tree nuts, fresh fruits, and soybean oil — protecting dairy, rice, millets, and GM crops. This is the politically most sensitive concession.
Digital Trade: India's IT/ITES export to the US exceeds USD 80 billion/year (services). The BTA's digital trade chapter could affect data flows, cloud computing rules, and e-commerce regulation.

Connection to this news: The "what's at stake" question is most acutely felt in textiles and pharma — India's most labour-intensive and strategically sensitive export sectors — where even small tariff shifts have large employment consequences.

WTO Most Favoured Nation (MFN) Principle and How the BTA Fits In

Under WTO rules, every member must extend the same tariff treatment to all other WTO members (the MFN principle, embedded in GATT Article I). A bilateral trade agreement is a lawful exception to MFN under GATT Article XXIV, which permits preferential tariff arrangements between two countries provided the deal covers "substantially all trade" and has a definite timeline for eliminating internal tariffs.

GATT Article I (MFN): any trade advantage granted to one WTO member must be extended to all WTO members.
GATT Article XXIV: exception allowing free trade agreements (FTAs) and customs unions; the deal must cover substantially all trade and eliminate tariffs within a reasonable timeframe (interpreted as 10 years).
India's average MFN applied tariff rate (2024): ~13%, one of the highest among major economies — the US often cites this as a structural barrier.
US average MFN applied tariff rate: ~3.4%.
An India-US BTA would be governed by Article XXIV's requirements; an "interim" deal that covers only select sectors risks WTO challenge unless it can demonstrate a clear path to a comprehensive deal.
India is a founding WTO member (January 1, 1995); the WTO dispute settlement mechanism has been used between the two countries on solar panels, steel, IT goods, and poultry.

Connection to this news: The June 2026 talks are structuring a deal that must comply with Article XXIV — the deal's scope (what percentage of trade it covers) determines whether it can stand up to scrutiny from other WTO members who may object to being excluded from the preferences.

US Reciprocal Tariff: History and Legal Architecture

The US "reciprocal tariff" imposed on India originates in Executive Order 14257 of April 2, 2025 ("Liberation Day"), issued under the International Emergency Economic Powers Act (IEEPA), which grants the President broad powers to regulate international commerce during a declared national emergency. India originally faced a 26% rate; a 90-day pause reduced this to 10% for all countries except China. After the US Supreme Court partly invalidated the IEEPA-based tariff mechanism in February 2026, the administration imposed a new 10% baseline rate by executive order on February 24, 2026, set to expire July 24, 2026.

Original India-specific rate (April 2025): 26% (above existing MFN duties)
Post-90-day-pause rate (all countries except China): 10%
Post-Supreme Court revised rate (India): 10%, effective February 24, 2026
Target rate under proposed BTA: 18% on originating Indian goods
The 10% tariff is levied over and above existing WTO MFN rates — meaning Indian goods face both the MFN duty and the 10% additional levy
Section 232 tariffs on steel (25%) and aluminium (10%), imposed under the Trade Expansion Act 1962, are separate and may be addressed in the BTA
The IEEPA (50 USC §1701 et seq.) grants emergency economic powers to the US President; its use for broad tariff imposition was the subject of the February 2026 Supreme Court ruling

Connection to this news: The July 24 expiry is the proximate driver of urgency in the June ministerial talks. The BTA would replace the temporary executive-order tariff with a negotiated, stable tariff architecture.

Key Facts & Data

Current US tariff on Indian goods: 10% (above MFN rates), expires July 24, 2026
Target BTA tariff on Indian goods: 18% on originating goods
India's goods exports to US (FY 2025-26): USD 87.31 billion
India's goods imports from US (FY 2025-26): USD 53.48 billion
US-India total goods trade (CY 2025): USD 149.4 billion
US-India services trade (CY 2024): USD 83.4 billion (balanced)
India's bilateral trade target with US: USD 500 billion by 2030
India's average MFN tariff rate: ~13%; US average MFN: ~3.4%
India supplies ~40% of US generic prescriptions by volume
India's pharma exports to US: approx. USD 8 billion/year
India's textile/apparel exports to US: approx. USD 12–14 billion/year
GATT Article XXIV: FTA exception to MFN, requiring coverage of "substantially all trade"
IEEPA: US legal basis for reciprocal tariffs; its scope was partly invalidated by US Supreme Court in February 2026
BTA Phase 1 framework announced: February 7, 2026; Phase 1 talks: June 23–24, 2026